PD-L1 is indeed part of one of the cancer-cell immune-escape mechanisms, but the dysfunction of this tumor-intrinsic IFN-γ signaling pathway is also an immune-checkpoint-inhibitor-resistance mechanism [21]. Here, CD274 is linked to cancer.